Track topics on Twitter Track topics that are important to you
Esanex, Inc., a clinical stage company developing Heat Shock Protein inhibitors for the treatment of cancer, today announced that it will present data at the 2018 American ...
-- Agreement reached with FDA on key elements of Phase 3 trial – -- SNX-5422 Granted Orphan Drug Designation -- Esanex, Inc., a clinical stage company develo...
We have published hundreds of Esanex, Inc. news stories on BioPortfolio along with dozens of Esanex, Inc. Clinical Trials and PubMed Articles about Esanex, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Esanex, Inc. Companies in our database. You can also find out about relevant Esanex, Inc. Drugs and Medications on this site too.